The Development of Biocatalysis as a Tool for Drug Discovery.


Journal

Chimia
ISSN: 0009-4293
Titre abrégé: Chimia (Aarau)
Pays: Switzerland
ID NLM: 0373152

Informations de publication

Date de publication:
27 May 2020
Historique:
entrez: 3 6 2020
pubmed: 3 6 2020
medline: 1 8 2020
Statut: ppublish

Résumé

Enzymes are versatile biocatalysts capable of performing selective reactions. The advantages of enzymes in comparison to classical chemistry including chemical catalysts are the generally milder process conditions and avoidance of harmful reactants. Their high selectivity and specificity are especially beneficial for the enzymatic synthesis of new products with potential applications in drug research. Therefore, in the past decades, the utilization of isolated enzymes or whole-cell biocatalysts has spread through a growing number of biotechnological industries. The applications comprise the production of chiral building blocks for the pharmaceutical and fine chemical industry, the enzymatic synthesis of drug metabolites for testing of toxicity, function, biological activity, degradation and the production of biocatalytically modified natural products, which all play a role in drug discovery. Especially Oreste Ghisalba's contributions, which paved the way for the industrial use of enzymes, will be considered in this review.

Identifiants

pubmed: 32482213
doi: 10.2533/chimia.2020.368
doi:

Substances chimiques

Biological Products 0
Enzymes 0

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

368-377

Auteurs

Jenny Schwarz (J)

Chair for Bioprocess Engineering, TU Dortmund University, Emil-Figge-Str. 66, D-44227 Dortmund, Germany.

Katrin Rosenthal (K)

Chair for Bioprocess Engineering, TU Dortmund University, Emil-Figge-Str. 66, D-44227 Dortmund, Germany.

Radka Snajdrova (R)

Global Discovery Chemistry, Novartis Pharma AG, Lichtstrasse, CH-4056 Basel, Switzerland.

Matthias Kittelmann (M)

Institutes for BioMedical Research, Novartis Pharma AG, Lichtstrasse, CH-4056 Basel, Switzerland.

Stephan Lütz (S)

Chair for Bioprocess Engineering, TU Dortmund University, Emil-Figge-Str. 66, D-44227 Dortmund, Germany.

Articles similaires

Humans Chondrocytes Osteoarthritis Matrix Metalloproteinase 13 Drug Discovery
Neural Networks, Computer Drug Discovery Humans Drug Repositioning
Drug Design Models, Chemical Endopeptidase Clp Drug Discovery Humans
Transformation, Genetic Plants, Genetically Modified Agrobacterium Biolistics Protoplasts

Classifications MeSH